FAQ


Where is Optinose’s Corporate headquarters?
1020 Stony Hill Road
Suite 300
Yardley, PA 19067
Where is Optinose incorporated?
Optinose is incorporated in the state of Delaware.
When is Optinose’s fiscal year-end?
Optinose’s fiscal year end is December 31st.
Who is Optinose’s independent registered public accounting firm?
Optinose’s independent registered public accounting firm is Ernst & Young, LLP.
Who is Optinose’s corporate counsel?
Optinose’s corporate counsel is Hogan Lovells US LLP
On which exchange is Optinose listed and what is the ticker symbol?
Optinose is traded on the NASDAQ stock exchange under the symbol OPTN.
When did Optinose go public?
Optinose went public on October 13, 2017.
How can I purchase shares of Optinose?
Shares of Optinose may be purchased through a stockbroker of your choice.
Does Optinose have a direct stock purchase plan?
No, Optinose does not offer a direct stock purchase plan.
Who is Optinose’s transfer agent and how do I contact them?
Optinose’s transfer agent is Broadridge Corporate Issuer Solutions, Inc. (Broadridge). You can find more information about how to contact Broadridge at: http://www.broadridge.com.
How can I replace my lost stock certificates?
Please contact Optinose’s transfer agent, Broadridge Corporate Issuer Solutions, Inc., at 1717 Arch Street, Suite 1300, Philadelphia, Pennsylvania 19103 or shareholder@broadridge.com. Broadridge can look up your records and make any necessary adjustments. There is generally a fee involved for replacing lost certificates.
How do I report a change of mailing address?
You must send both your old and new addresses to Optinose’s transfer agent, Broadridge Corporate Issuer Solutions, Inc., by U.S. mail. Each stockholder in question must sign the request for an address change.
Where can I view documents that Optinose has filed with the Securities & Exchange Commission (SEC)?
Optinose’s SEC filings can be accessed under "Financial Reporting" in the "Investors" section of our corporate website or www.sec.gov.
Where can I find recent Optinose press releases?
You can view Optinose’s recent press releases by visiting the “Newsroom” section of the website. If you would like to receive press release email alerts, please visit the “Investors” section of the corporate website and choose the "Email Alerts" icon.
Who can I contact if I am a member of the media?
For media inquiries, please send an email to Kate Traynor, Sloane & Company, Ktraynor@sloanepr.com.
How do I contact Investor Relations with a question or request?
For investor related questions, please send an email to investors@optinose.com